NCT07136766

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

An 18 Week Study to Assess the Efficacy of a Test Product Used in Combination With a Currently Marketed Prescription Product

• Status: Enrolling By Invitation
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Good Molecules, LLC · Industry
• Sex: Female
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess the efficacy (ability to produce a desired or intended result) of a topical product (applied to the skin) to improve skin lightness, skin condition and appearance (hyperpigmentation \[dark spots\], brightness/radiance \[healthy vibrant appearance\], skin texture \[smoothness\]) on \] the face over a period of eighteen (18) weeks. The data collected may support the company in developing marketing claims for its product.

Conditions

• Hyperpigmentation

Interventions

Type	Name	Description
DRUG	Facial Toner	Brightening Toner
OTHER	Placebo Toner	Placebo Control Toner

Timeline

• Start date: 2025-09-10
• Primary completion: 2026-02-16
• Completion: 2026-02-16
• First posted: 2025-08-22
• Last updated: 2025-08-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study